InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by LEBEL FRANCOIS, Directeur Médical. Director active across 3 companies, notably SPECTRUM PHARMACEUTICALS INC. In total, 9 reports have been logged. Split: 0 buy · 7 sells. Total volume traded: €94k. History available since 22 June 2021. The latest transaction was filed on 21 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations9 total
405,040 shares0Common Stock, $0.001 par valueSEC:0001209191-22-039063:0
1,205 shares@ US$1.352.5% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-023224:0
25,130 shares@ US$0.70527.0% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-019341:0
13,466 shares@ US$0.70313.9% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-012928:0
7,363 shares@ US$2.20323.4% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-064002:0
7,363 shares@ US$2.20341.3% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-064002
5,821 shares@ US$4.08658.7% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-042775
5,821 shares@ US$4.08633.2% of flowCommon Stock, $0.001 par valueSEC:0001209191-21-042775:0
65,000 sharesCommon StockSEC:0001209191-16-088699:0
9 of 9 declarations
About LEBEL FRANCOIS
François Lebel is the Chief Medical Officer of SPECTRUM PHARMACEUTICALS INC. In this role, he is responsible for the medical direction and clinical strategy of the company. SPECTRUM PHARMACEUTICALS INC. is committed to developing innovative treatments for serious diseases. François plays a key role in the strategic direction of medical initiatives.
